Drugs of anesthesia, central nicotinic receptors and Parkinson's disease.
暂无分享,去创建一个
[1] V. Fodale,et al. Drugs of anesthesia, central nicotinic receptors and post‐operative cognitive dysfunction , 2003, Acta anaesthesiologica Scandinavica.
[2] M. O'Neill,et al. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. , 2002, Current drug targets. CNS and neurological disorders.
[3] V. Fodale,et al. Laudanosine, an atracurium and cisatracurium metabolite. , 2002, European journal of anaesthesiology.
[4] J. Chad,et al. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. , 1998, European journal of pharmacology.
[5] C. Okuda,et al. The interaction of pancuronium and vecuronium with cardiac muscarinic receptors , 1987, Acta anaesthesiologica Scandinavica.
[6] Dominique Muller,et al. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia , 2002, Brain Research Bulletin.
[7] D. Bertrand,et al. Cerebrospinal fluid concentrations of atracurium, laudanosine and vecuronium following clinical subarachnoid hemorrhage , 2002, Acta anaesthesiologica Scandinavica.
[8] K. Fuxe,et al. Central nicotinic receptors, neurotrophic factors and neuroprotection , 2000, Behavioural Brain Research.
[9] G. Hall,et al. Parkinson's disease and anaesthesia. , 2002, British journal of anaesthesia.
[10] J. Drago,et al. Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice , 2001, British journal of pharmacology.
[11] V. Fodale,et al. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite , 2003, Acta anaesthesiologica Scandinavica.
[12] V. Fodale,et al. The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anesthesia. , 2003, Anesthesia and analgesia.